Shanghai United Imaging Healthcare Co (SHSE:688271) Research & Development: ¥1,841 Mil (TTM As of Mar. 2026)


SHSE:688271 Shanghai United Imaging Healthcare Co Ltd SHSE:688271
78 GF Score
Price ¥98.23
GF Value ¥172.51
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai United Imaging Healthcare Co Research & Development?

Shanghai United Imaging Healthcare Co SHSE:688271 -3.22% 78 Research & Development is ¥1,841 Mil as of Mar. 2026. GuruFocus rates SHSE:688271 with a GF Score™ of 78/100 and a GF Value™ of ¥172.51 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Shanghai United Imaging Healthcare Co's Research & Development for the three months ended in Mar. 2026 was ¥378 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥1,841 Mil.

Shanghai United Imaging Healthcare Co  (SHSE:688271) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Shanghai United Imaging Healthcare Co Research & Development Related Terms

Shanghai United Imaging Healthcare Co Research & Development Historical Data

* Premium members only.

The historical data trend for Shanghai United Imaging Healthcare Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai United Imaging Healthcare Co Research & Development Chart

Shanghai United Imaging Healthcare Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 968.35 1,306.28 1,728.54 1,761.47 1,841.94

Shanghai United Imaging Healthcare Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 378.87 387.59 483.84 591.65 377.95
SHSE:688271
78GF Score
Shanghai United Imaging Healthcare Co Ltd SHSE:688271
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai United Imaging Healthcare Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,841 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥1,841 Mil mean?
Shanghai United Imaging Healthcare Co (SHSE:688271) has a Research & Development of ¥1,841 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Shanghai United Imaging Healthcare Co and its competitors.
Is Shanghai United Imaging Healthcare Co's Research & Development too high?
Shanghai United Imaging Healthcare Co's current Research & Development is ¥1,841 Mil. Overall, Shanghai United Imaging Healthcare Co has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai United Imaging Healthcare Co's Research & Development compare to ABT and SYK?
Shanghai United Imaging Healthcare Co's Research & Development of ¥1,841 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Shanghai United Imaging Healthcare Co and its competitors. Shanghai United Imaging Healthcare Co's current Research & Development is ¥1,841 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai United Imaging Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai United Imaging Healthcare Co (SHSE:688271) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥172.51, compared to a current price of ¥98.23 — trading 43.1% below its estimated fair value. The current Research & Development is ¥1,841 Mil. Shanghai United Imaging Healthcare Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Shanghai United Imaging Healthcare Co (SHSE:688271), the current Research & Development is ¥1,841 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai United Imaging Healthcare Co (SHSE:688271) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai United Imaging Healthcare Co stock appears to be undervalued. The current stock price of ¥98.23 is trading 43.1% below its estimated GF Value™ of ¥172.51. GuruFocus considers Shanghai United Imaging Healthcare Co to be Significantly Undervalued.

Key valuation signals for SHSE:688271:

  • Research & Development: ¥1,841 Mil
  • GF Value™: ¥172.51 vs. price of ¥98.23 (43.1% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai United Imaging Healthcare Co Business Description

Address No. 2258, Chengbei Road, Jiading District, Shanghai, CHN, 201807
Shanghai United Imaging Healthcare Co Ltd provides customers with high-performance medical imaging equipment, radiotherapy products, life science instruments, and medical digitalization and intelligent solutions. The company's products include MRI systems, CT scanners, X-ray imaging equipment, molecular imaging systems, radiotherapy linear accelerators, and life science instruments.
78GF Score

Get the complete analysis for SHSE:688271

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥98.23
Price
¥172.51
GF Value